These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33613429)

  • 61. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
    Iizuka T; Sakai F
    Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Three phenotypes of anti-N-methyl-D-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis.
    DeSena AD; Greenberg BM; Graves D
    Pediatr Neurol; 2014 Oct; 51(4):542-9. PubMed ID: 25070939
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China.
    Zhang Y; Liu G; Jiang MD; Li LP; Su YY
    Clin Neurophysiol; 2017 Jul; 128(7):1227-1233. PubMed ID: 28527387
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of Risk Factors for a Poor Prognosis in Patients with Anti-
    Mo Y; Wang L; Zhu L; Li F; Yu G; Luo Y; Ni M
    J Clin Neurol; 2020 Jul; 16(3):438-447. PubMed ID: 32657065
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical Features and Early Recognition of 242 Cases of Autoimmune Encephalitis.
    Yang M; Lian Y
    Front Neurol; 2021; 12():803752. PubMed ID: 35095744
    [No Abstract]   [Full Text] [Related]  

  • 66. Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis.
    Peng Y; Liu B; Pei S; Zheng D; Wang Z; Ji T; Pan S; Shen HY; Wang H
    Front Immunol; 2019; 10():905. PubMed ID: 31214158
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-NMDAR encephalitis after resection of melanocytic nevi: report of two cases.
    Yang XZ; Cui LY; Ren HT; Qu T; Guan HZ
    BMC Neurol; 2015 Sep; 15():165. PubMed ID: 26370233
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Focus on autonomic dysfunctions in anti-NMDAR encephalitis: a case report.
    Ren C; Nai Y; Lv W; Liu H; Chen Q; Sun ZW; Wang JH; Guan LN; Gong L; Wang XT
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10970-10975. PubMed ID: 31858566
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Cognitive function and cerebral blood perfusion changes in patients with anti-N-methyl-D-aspartate receptor encephalitis].
    Guo YY; Lü XY; Wu Y; Chen Y; Wei Q; Zhou N; Wang K; Tian YH
    Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1942-1946. PubMed ID: 32629593
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
    Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
    Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pulmonary embolism complicated the course of anti-N-methyl-D aspartate receptor encephalitis in a pediatric intensive care unit setting: a case report.
    Ekinci F; Yildizdas D; Horoz OO; Yontem A; Gul Mert G
    Postgrad Med; 2021 Jan; 133(1):102-107. PubMed ID: 32703058
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk Factors and Prognosis in Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis Requiring Prolonged Mechanical Ventilation.
    Lin J; Xiang Q; Liu X; Li J
    Front Neurol; 2022; 13():814673. PubMed ID: 35222249
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
    Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
    Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Clinical featuers of adult patients with post-viral-encephalitis autoimmune encephalitis].
    Fu ZY; Ren HT; Xue LP; Tian YN; Fan SY; Zhao YH; Lin N; Yin HX; Jiang N; Peng B; Cui LY; Guan HZ
    Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1933-1936. PubMed ID: 32629591
    [No Abstract]   [Full Text] [Related]  

  • 75. Influential factors and predictors of anti-N-methyl-D-aspartate receptor encephalitis associated with severity at admission.
    Huang XX; Zhang S; Yan LL; Tang Y; Wu J
    Neurol Sci; 2021 Sep; 42(9):3835-3841. PubMed ID: 33483886
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
    Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
    Front Neurol; 2020; 11():280. PubMed ID: 32431657
    [No Abstract]   [Full Text] [Related]  

  • 77. Clinical Characteristics and Follow-Up of Seizures in Children With Anti-NMDAR Encephalitis.
    Zhang J; Sun J; Zheng P; Feng S; Yi X; Ren H; Chen Q
    Front Neurol; 2021; 12():801289. PubMed ID: 35069429
    [No Abstract]   [Full Text] [Related]  

  • 78. [Anti-N-methyl-D-aspartate receptor encephalitis:clinical analysis of 11 cases].
    Wu Y; Shi Y; Zhang M; Liu J; Zhou Y; Huang Y; Liu H; Ma M; Zhang J
    Zhonghua Yi Xue Za Zhi; 2015 Sep; 95(35):2857-60. PubMed ID: 26815189
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis.
    Peng Y; Zheng D; Zhang X; Pan S; Ji T; Zhang J; Shen HY; Wang HH
    Front Immunol; 2019; 10():103. PubMed ID: 30792710
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical Relevance of Cerebrospinal Fluid Antibody Titers in Anti-
    Cai MT; Zheng Y; Wang S; Lai QL; Fang GL; Shen CH; Xu YF; Zhang YX; Ding MP
    Brain Sci; 2021 Dec; 12(1):. PubMed ID: 35053749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.